"Imidazolines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds based on reduced IMIDAZOLES containing a single double bond.
| Descriptor ID |
D048288
|
| MeSH Number(s) |
D03.383.129.308.436
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Imidazolines".
Below are MeSH descriptors whose meaning is more specific than "Imidazolines".
This graph shows the total number of publications written about "Imidazolines" by people in this website by year, and whether "Imidazolines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Imidazolines" by people in Profiles.
-
De novo design of a fluorescence-activating ?-barrel. Nature. 2018 09; 561(7724):485-491.
-
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia. Clin Cancer Res. 2016 Feb 15; 22(4):868-76.
-
Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2015 Sep; 76(3):587-95.
-
Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy. Bioorg Med Chem. 2014 Aug 01; 22(15):4001-9.